Validation of a new cancer-related VTE model

Todays Updates

Cell Therapy Deramiocel Meets Primary End Point in Phase 3 DMD Cardiomyopathy Trial Isabella Ciccone, MPH

Capricor Therapeutics anticipates that detailed phase 3 data from the HOPE-3 study will be submitted for presentation at a future scientific meeting and for publication in a peer-reviewed journal.

EPX-100 Shows Promising Seizure Reduction in Ongoing Open-Label Extension Louie Pasculli

New data from the open-label extension of Harmony Biosciences’ Phase 3 ARGUS trial show that EPX-100 (clemizole) achieved a median 50% reduction in countable motor seizures in patients with Dravet Syndrome.

Z-Rostudirsen Meets Primary End Point in Phase 1/2 DELIVER Trial for Duchenne Muscular Dystrophy Isabella Ciccone, MPH

Long-term treatment with z-rostudirsen over 24 months showed sustained functional improvements across all end points in patients with Duchenne muscular dystrophy amenable to exon 51 skipping.

Michael Sperling, MD, on AES Lifetime Achievement Award, Evolution in Epilepsy Care Michael R. Sperling, MD, Louie Pasculli

Michael Sperling, MD, Baldwin Keyes Professor of Neurology at Vice Chair for Research at the Sidney Kimmel Medical College, spoke about the significance of receiving the Founders Award and the current state of epilepsy.

Validation of a new cancer-related VTE model

Latest News

Discussing INTEGUMENT-INFANT and Roflumilast Cream 0.05% in Atopic Dermatitis, With Rocco Serrao, MD

Mild to Moderate Psoriasis Linked with Indicators of Suboptimal Treatment, Disease Control

AI in Dermatology: Discussing Downsides to the Adoption of Artificial Intelligence

Potential Causal Relationship Identified Between Depression, Psoriasis

Dupilumab Superior in Analysis of Monoclonal Antibodies for Atopic Dermatitis

HS Specialists Express Support for Earlier Use of Biologics Among Patients

Todays Updates

Cell Therapy Deramiocel Meets Primary End Point in Phase 3 DMD Cardiomyopathy Trial Isabella Ciccone, MPH

EPX-100 Shows Promising Seizure Reduction in Ongoing Open-Label Extension Louie Pasculli

Z-Rostudirsen Meets Primary End Point in Phase 1/2 DELIVER Trial for Duchenne Muscular Dystrophy Isabella Ciccone, MPH

Michael Sperling, MD, on AES Lifetime Achievement Award, Evolution in Epilepsy Care Michael R. Sperling, MD, Louie Pasculli

Thunderstorms Linked to Surge in Asthma ER Visits

Redefining Transplant Possibilities: The Emergence of Kidney Xenotransplants

Febuxostat Lowers Serum Uric Acid More Effectively in Gout Patients With CKD

Todays Updates

Cell Therapy Deramiocel Meets Primary End Point in Phase 3 DMD Cardiomyopathy Trial Isabella Ciccone, MPH

EPX-100 Shows Promising Seizure Reduction in Ongoing Open-Label Extension Louie Pasculli

Z-Rostudirsen Meets Primary End Point in Phase 1/2 DELIVER Trial for Duchenne Muscular Dystrophy Isabella Ciccone, MPH

Michael Sperling, MD, on AES Lifetime Achievement Award, Evolution in Epilepsy Care Michael R. Sperling, MD, Louie Pasculli

Thunderstorms Linked to Surge in Asthma ER Visits

Redefining Transplant Possibilities: The Emergence of Kidney Xenotransplants

Febuxostat Lowers Serum Uric Acid More Effectively in Gout Patients With CKD

Latest News

News All Time

How to Recognize and Treat Atopic Dermatitis in Patients with Skin of Color

Expert Consensus Provides Recommendations on Dermoscopy Standards for PAs

Discussing Granuloma Annulare, Lichenoid Disorders, and Social Media, With Shannon Trotter, DO

Lebrikizumab Benefits AD Patients With Skin of Color, With Vinay Mehta, MD Vinay Mehta, MD

Discussing New Topical Drugs for Atopic Dermatitis in Younger Patients, With Peter Lio, MD Peter Lio, MD

Lebrikizumab Effectively Treats AD in Patients with Skin of Color, With Vinay Mehta, MD Vinay Mehta, MD

The Medical Sisterhood: Balance and Boundaries in the Holiday Season, With Angela Lamb, MD Mona Shahriari, MD, FAAD, Angela Lamb, MD

Skin of Color Savvy: Hair-Care Challenges in Dermatology, With Amy McMichael, MD, and Kayla Taylor, MD Amy McMichael, MD, Kayla Taylor, MD

Non-Steroidal Topicals: A Game-Changer for Pediatric Atopic Dermatitis, With Emily Becker, MD Emily Becker, MD

AI’s Use in Non-Patient-Facing Dermatology Spaces, With Joseph Gatti, DMSc, MPAS, MBA, PA-C

Atopic Diseases Significantly Raise the Risk of Post-Surgical Complications

Progress with Emerging TYK2 Inhibitors for Psoriasis, With Benjamin Lockshin, MD Benjamin Lockshin, MD, FAAD

Discussing Zasocitinib and Other TYK2 Inhibitors for Psoriasis, With Ronald Vender, MD Ronald Vender, MD

Discussing Findings on Secukinumab (Cosentyx) Efficacy Over 4 Years in HS, With Martina Porter, MD Martina Porter, MD

Tapinarof Shows Early, Sustained Benefits in Pediatric Atopic Dermatitis, With Druhan Howell, MD Druhan Howell, MD

ARCADIA LTE: Long-term Nemolizumab Effective in Adolescents with Atopic Dermatitis

Recommended News For You

A specific drug combination is being tested in a clinical trial for the deadly brain cancer glioblastoma.

Shorter, less intense regimen still effective for HPV-linked throat cancer, study shows

Older Men Increasingly Overtreated for Prostate Cancer, Study Suggests

New study highlights success of financial toxicity tumor board in reducing cancer treatment costs

If CD19 CAR T-Cell Therapy Fails in Lymphoma, Try a CD22 Version

A study suggests that you should disregard the "pack-years" when determining your eligibility for lung cancer screening.

Transplantation Fails to Improve Survival in Mantle Cell Lymphoma

Recommended Articles For You

Uncovering the Secrets of CA19-9: A Blood Test for Cancer Diagnosis

Next-Gen Cancer Therapies: Radiopharmaceuticals, Immuno-Oncology, and Biologic Breakthroughs

The Mysterious World of Petechiae: Exploring Causes and Treatments

The Genetics of Bernard Soulier Syndrome: What We Know so Far

Whats more on Hidoc Dr.

Medical Updates

KOL Videos

Surveys

Events

Featured News

Featured Articles

Featured Events

Featured KOL Videos

Quick Links

Verification

Welcome to Hidoc Dr.